Photo via The Guardian

Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’

Read the original at The Guardian ↗
Cite

Horton, H. (2026, November 20). Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’. The Guardian. https://www.theguardian.com/society/2026/nov/20/pill-pancreatic-cancer-breakthrough-daraxonrasib

Dated from the outlet's own feed. Check the original for its byline.

The Guardian · collected 2026-11-20 · by Helena Horton

Quick Summary

Doctors are celebrating early results from a trial of a new pill called daraxonrasib for pancreatic cancer, which showed that in one in 12 patients, the cancer became undetectable. In the trial involving 61 patients with advanced cancer that had spread, tumours stopped growing in 90% of cases, and over 60% saw their tumours shrink or disappear. Dr. Wungki Park, who presented the findings at a symposium in Barcelona, called it the closest to a cure seen in decades, noting the unprecedented rate of tumour disappearance. While the pill cannot yet be considered a definitive cure, it offers hope for extending survival times, with 76.6% of patients surviving a year compared to 40-45% for chemotherapy alone.
Written by AI on 2026-11-20, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

Scientists have reported a significant breakthrough in pancreatic cancer treatment with a new daily pill called daraxonrasib, which has shown promising results in early trials. In these trials, the cancer became undetectable in one in 12 patients who received the drug along with chemotherapy, and tumours stopped growing in nearly all of the 61 participants diagnosed with advanced pancreatic cancer that had spread to other parts of the body. Although the pill cannot yet be considered a cure, it offers hope for extending the lives of patients with one of the deadliest and hardest-to-treat cancers, which has the lowest survival rate of all common cancers in the UK. Dr. Sam Godfrey of Cancer Research UK described the development as "the biggest leap forward in decades."

Written for “Pill Breakthrough for Pancreatic Cancer” on 2026-11-21, grounded in this article and the 1 other(s) covering the same event.

How they differ

2 outlets covered “Pill Breakthrough for Pancreatic Cancer”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

The GuardianThis outlet20 Nov

Doctors are celebrating early results from a trial of a new pill called daraxonrasib for pancreatic cancer, which showed that in one in 12 patients, the cancer became undetectable. In the trial involving 61 patients with advanced cancer that had spread, tumours stopped growing in 90% of cases, and over 60% saw their tumours shrink or disappear. Dr. Wungki Park, who presented the findings at a symposium in Barcelona…

Pill to treat pancreatic cancer hailed as ‘biggest breakthrough in decades’ (this article)
BBC20 Nov

Experts are heralding a daily pill called daraxonrasib as a major breakthrough in pancreatic cancer treatment, with some patients showing undetectable tumors on scans. In a trial involving 61 recently diagnosed patients with advanced pancreatic cancer, tumors stopped growing in 90% of participants, and for around 8%, or one in 12, tumors became undetectable. While this is considered highly promising, doctors…

Massive hope for pancreatic cancer pill after trial saw tumours vanish →

Compared with similar articles

This article reads unscored and hedges 16% of its claims. Each row says how that neighbour differs.
BBC News
Hedges 6 of 21 claims Outlet record 65/100

Story

Pill Breakthrough for Pancreatic Cancer
Health · 2 article(s) covering the same event. See how they differ ↑
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
19
sentences that state something as happening or true
Uncertain
16%
3 of 19 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
64/100
The Guardian's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
2
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-20 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

The Guardian · 3744 article(s) · 8 correction(s) detected
Running correction rate · 8 correction(s)

Who wrote this

Helena Horton
29 article(s) here · 1 carrying a prediction
Though doctors have said the pill cannot yet be considered a cure, and they do not know how long it can keep the disease at bay, they have said it is encouraging news because it appears it will offer patients more time, even if it does not cause full remission.
The Labour MP for Birmingham Yardley told LBC: “The ability of these men to find each other on websites that you and I could just log on to now – it just means that these cases are going to keep on coming.”
Ministers will drop plans to ban foie gras imports into the UK in order to smooth a trade deal with the EU that will be announced this week.
Lisa Nandy, the culture secretary, said the investment would be “the first dedicated fund for lidos that this country has produced” and would form part of a wider public leisure facilities programme.
Rani Ghosh, an independent toxicologist, said: “Some reactions to unsafe cosmetics may be visible, such as irritation, swelling or changes to the skin.
Reform UK has launched what it is calling a newspaper, featuring large pictures of Nigel Farage, which the party hopes will replace mainstream media for its supporters.
They will appear at the Old Bailey on 20 November.
Now he will become the first prime minister to appear on the popular TV show Gogglebox, in a special charity episode on Friday.
The Downton Abbey actor Hugh Bonneville split from his wife, Lulu Williams, in 2023 after 25 years, and in 2019, Colin Firth announced his separation from wife, Livia Giuggioli, after 22.
Mini pumpkins will have to be used, and some have suggested that those celebrating the spooky festival draw faces on vegetables instead of carving them.
Also by Helena Horton
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 29 articles by Helena Horton →

Topics

Cancer Research UK’s Daraxonrasib Memorial Sloan Kettering Cancer Center New York the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona.

Subjects

Cancer Research UK’s ORG · 1× Memorial Sloan Kettering Cancer Center ORG · 1× Michelle Mitchell PERSON · 1× NHS ORG · 1× New York GPE · 1× Wungki Park PERSON · 1×

Narrative

Dr Wungki Park, a gastrointestinal medical oncologist at Memorial Sloan Kettering Cancer Center in New York, who presented the findings, said “this is the closest to cure”, adding that he had never seen so many tumours disappear in patients whose cancer had spread.
framing: assertive · carried by 1 article(s) · first seen 2026-11-20
Though doctors have said the pill cannot yet be considered a cure, and they do not know how long it can keep the disease at bay, they have said it is encouraging news because it appears it will offer patients more time, even if it does not cause full remission.

Claims (19 extracted, 3 hedged)

A pill that can shrink and potentially eliminate pancreas tumours is being hailed as the biggest breakthrough treatment for the cancer in decades. asserted
that → shrink → decades
In one in 12 of the patients given the drug, daraxonrasib, during a trial, the cancer became undetectable, and the tumours stopped growing in almost all of the 61 patients. asserted
tumours → give → patients
The trial participants had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body. asserted
that → diagnose → body
Though doctors have said the pill cannot yet be considered a cure, and they do not know how long it can keep the disease at bay, they have said it is encouraging news because it appears it will offer patients more time, even if it does not cause full remission. asserted
it → say → remission
Half of all people diagnosed with pancreatic cancer die within three months, and only about 3% of patients survive for five years when the disease spreads to other organs. asserted
disease → diagnose → organs
It has the lowest survival rate of all common cancers in the UK. asserted
It → have → UK
Patients were followed for a year and a half during the trial on average and some did not see the cancer return during this period. asserted
cancer → follow → period
Longer studies will be conducted to see if any of the cancers can be put into remission. asserted
any → conduct → remission
During the trial, tumours stopped growing in 90% of patients, just over 60% of patients had their tumours shrink or disappear, and for about 8% of patients tumours became undetectable on CT scans. asserted
tumours → stop → scans
A year after starting treatment, 76.6% of patients were alive; usually 40-45% of patients given chemotherapy alone survive a year. asserted
% → start → chemotherapy
Dr Wungki Park, a gastrointestinal medical oncologist at Memorial Sloan Kettering Cancer Center in New York, who presented the findings, said “this is the closest to cure”, adding that he had never seen so many tumours disappear in patients whose cancer had spread. asserted
cancer → present → patients
He presented the findings at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona. asserted
He → present → Barcelona
“We are beginning to see not only a higher percentage of tumour response rates, but also deeper responses and a near doubling in the duration of disease control, which may eventually translate into longer survival,” he said. uncertain
he → begin → survival
Just imagine, in an average of 18 months your disease just disappears on the CT scan … that’s closest to complete remission … it’s incredible.” asserted
it → imagine → remission
Daraxonrasib is a KRAS inhibitor treatment, which works by locking on to and shutting off certain mutations found in most pancreatic cancers. asserted
which → work → cancers
These mutations drive tumour growth. asserted
mutations → drive → growth
There are hopes the treatment could work for dozens of other cancers because they can have similar mutations. uncertain
they → be → mutations
Michelle Mitchell, Cancer Research UK’s chief executive, said more research was needed, but added: “This is the biggest leap forward we’ve seen in decades for pancreatic cancer patients and could offer real hope to people facing one of the deadliest and most difficult-to-treat cancers. “These results raise the exciting possibility that this breakthrough could eventually pave the way for treating other cancers that carry Kras gene mutations. uncertain
that → say → mutations
More trials are now needed before this treatment can be assessed for use on the NHS and despite this advance, pancreatic cancer survival is still very low.” asserted
survival → need → advance
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support